A Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Famotidine vs Placebo for the Treatment of Non-Hospitalized Symptomatic Adults With COVID-19

January 26, 2021 | Community/Outpatient Based | 

80mg x 3 daily for a maximum of 14 days, or until hospital admission

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!